Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc > ONC sponsoring Cgy Flames post game radio

<< Previous

Bullboard Posts

Next >>

Comment by lonc17on Nov 01, 2023 1:00pm

168 Views

Post# 35711578

RE:ONC sponsoring Cgy Flames post game radio

Very strange for ONC to spend advertising dollars for such a small, targeted market.

Typically their boiler room activity is a very broad based form of fake journalism intended to attract naive penny stock investors.

Here's an optimistic view:

They are days away from announcing a major big pharmaceutical partnership and they want to give hometown Calgarians one last chance for a big windfall.

Funny if true.

<< Previous

Bullboard Posts

Next >>

Calibre discovers significant gold in Newfoundland